This topic contains a solution. Click here to go to the answer

Author Question: Discuss Zimbardo's study. Explain what it tells us about social interactions in prison and the ... (Read 99 times)

acc299

  • Hero Member
  • *****
  • Posts: 569
Discuss Zimbardo's study. Explain what it tells us about social interactions in prison and the problems that it raised in the scientific community.
 
  What will be an ideal response?

Question 2

Sociologists think that community
 
  a. has been weakened in modern society.
  b. may persist in modern society.
  c. requires more individual effort in modern society.
  d. all of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nhea

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

The ideal answer should include:
 Outline Zimbardo's study.
 Note the ethical dilemmas this study posed and the effects on future research.
 Explain what we learn from Zimbardo's study.
 Craft an argument about the effect of structures on power.

Answer to Question 2

D




acc299

  • Member
  • Posts: 569
Reply 2 on: Jul 2, 2018
:D TYSM


connor417

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library